Molecular group:
Complement
Molecule/Cell:
C9
Plasmodium strain:
Plasmodium berghei ANKA
pRBC infection titer:
5 x 10^5
Mouse genetic background (Con):
C57BL/6
Experimental treatment group (EG):
anti-C9
Lethal infection (Con):
yes
Lethal infection (EG):
yes
Pathology (Con):
CM (100%)
Pathology (EG):
CM (~80%)
Parasitemia (EG vs Con):
N.I.
Additional phenotypes (EG vs Con):
Delayed onset of CM
Refs:
Ramos et al., 2011, J Immunol
Hyperlink: